The Cigna Group (NYSE:CI) Shares Sold by Lmcg Investments LLC

Lmcg Investments LLC decreased its holdings in shares of The Cigna Group (NYSE:CI) by 19.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 16,125 shares of the health services provider’s stock after selling 3,920 shares during the period. Lmcg Investments LLC’s holdings in The Cigna Group were worth $4,453,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Ulland Investment Advisors LLC grew its position in The Cigna Group by 2,500.0% during the third quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock worth $36,000 after buying an additional 100 shares during the period. Prospera Private Wealth LLC acquired a new stake in The Cigna Group during the 3rd quarter valued at $37,000. ORG Wealth Partners LLC purchased a new stake in The Cigna Group in the 4th quarter valued at about $34,000. Harbor Capital Advisors Inc. purchased a new position in shares of The Cigna Group during the 3rd quarter worth about $45,000. Finally, Intact Investment Management Inc. acquired a new stake in shares of The Cigna Group in the third quarter worth approximately $69,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

The Cigna Group Price Performance

Shares of NYSE:CI opened at $284.16 on Tuesday. The company has a quick ratio of 0.72, a current ratio of 0.72 and a debt-to-equity ratio of 0.71. The firm has a 50-day simple moving average of $301.37 and a 200 day simple moving average of $326.80. The Cigna Group has a fifty-two week low of $262.03 and a fifty-two week high of $370.83. The company has a market cap of $79.04 billion, a PE ratio of 26.81, a P/E/G ratio of 0.77 and a beta of 0.54.

The Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.22 by $0.29. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. The business had revenue of $63.70 billion for the quarter, compared to the consensus estimate of $59.58 billion. During the same quarter last year, the business posted $6.77 EPS. The business’s revenue was up 29.8% on a year-over-year basis. On average, sell-side analysts anticipate that The Cigna Group will post 28.5 EPS for the current year.

The Cigna Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, December 19th. Shareholders of record on Wednesday, December 4th were given a $1.40 dividend. This represents a $5.60 annualized dividend and a yield of 1.97%. The ex-dividend date was Wednesday, December 4th. The Cigna Group’s dividend payout ratio (DPR) is 52.83%.

Analyst Ratings Changes

CI has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft cut their price target on shares of The Cigna Group from $398.00 to $394.00 and set a “buy” rating on the stock in a research note on Monday, November 4th. Cantor Fitzgerald reiterated an “overweight” rating and set a $400.00 target price on shares of The Cigna Group in a report on Wednesday, October 23rd. Truist Financial lowered their target price on The Cigna Group from $420.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Barclays boosted their price target on The Cigna Group from $405.00 to $420.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 5th. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $394.00 price objective (up previously from $392.00) on shares of The Cigna Group in a research report on Tuesday, November 5th. One analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of $395.93.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.